SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-069318
Filing Date
2024-06-05
Accepted
2024-06-05 16:12:34
Documents
12
Period of Report
2024-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-20240604.htm   iXBRL 8-K 117109
2 EX-10.1 xene-ex10_1.htm EX-10.1 340058
  Complete submission text file 0000950170-24-069318.txt   629718

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20240604.xsd EX-101.SCH 30824
15 EXTRACTED XBRL INSTANCE DOCUMENT xene-20240604_htm.xml XML 4688
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 241022136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)